#USA #Miami #Amavita #IAOCR #Dr. Martinez-Clark

Amavita Heart and Vascular Health Secures Reputable IAOCR Certifications

Amavita Heart and Vascular Research Services LLC, a key segment of Amavita Heart and Vascular Health™, has reached a significant milestone by earning the GCSA Global Quality Standard for Clinical Research Sites. This accomplishment not only highlights the organization’s dedication to superior clinical research practices but also comes on the heels of Dr. Pedro Martinez Clark, the Principal Investigator at Amavita, attaining the QM-IAOCR Internationally Qualified Clinical Research Investigator Accreditation.

The pursuit of these prestigious certifications reflects Amavita's unwavering commitment to upholding international standards in clinical research. In order to qualify for both the GCSA and IAOCR accreditations, Amavita underwent an extensive assessment process focusing on the operational processes crucial for effective clinical trials. This included a thorough evaluation of the competencies necessary for Clinical Research Investigators, underscoring the organization's determination to implement best practices in clinical trial management, patient safety, and compliance with regulatory requirements.

Dr. Martinez-Clark expressed, “We are thrilled to receive the GCSA site certification, which validates our team's commitment to conducting clinical trials with highest quality and integrity.” This achievement not only confirms Amavita's efforts but also improves the trust and confidence of sponsors and participants in their research, positioning Amavita as a center of excellence in the cardiovascular specialty.

The significance of the GCSA Certification lies in its status as the world's only internationally recognized quality standard tailored for clinical trial sites. Achieving this certification demonstrates Amavita's proficiency across critical operational domains required for delivering exceptional experiences for both patients and sponsors throughout the clinical trial process. The site met stringent standards encompassing various important areas, from feasibility studies to patient engagement and governance practices.

Colette Donaghy, the director of assessment at IAOCR and GCSA, noted, “Amavita Research's team has clearly implemented effective processes that support the success of their clinical trials.”

Both the IAOCR and GCSA utilize extensive assessment frameworks created and endorsed by industry experts. The GCSA standard was established with input from a global advisory board consisting of major stakeholders in the field, while IAOCR has developed accreditation standards in collaboration with international task forces comprised of experts specific to clinical research.

Up to this point, clinical research has been governed by legislation, but the introduction of GCSA provides standard-setting procedures for research sites to meet the expectations of sponsors and clinical research organizations (CROs). This acknowledgement empowers sites to communicate their capabilities and distinguish themselves in an increasingly competitive market.

Going beyond mere certification, GCSA offers individual support to assist sites in reaching the requisite standards, collaborating closely with them to achieve development goals.

About IAOCR
The International Accrediting Organization for Clinical Research (IAOCR) stands as the only entity meeting international standards for the accreditation of clinical research professionals. Their comprehensive competence verification aims at diminishing risks related to clinical studies and ensuring that new treatments reach markets more safely and efficiently.

About GCSA
The GCSA offers a quality benchmark for clinical trial sites, focusing on effective operational practices necessary for providing exemplary services to patients and sponsors. Developed over several years through industry research and expert consultations, GCSA seeks to resolve pivotal challenges in the sector and foster beneficial collaborations between sites and sponsors to enhance patient outcomes.

In summary, Amavita Heart and Vascular Health’s recent certifications from IAOCR and GCSA not only solidify its reputation but also serve as a cornerstone for future growth, with an eye towards continuing to meet global standards of excellence.

For more details, please visit iamocr.com.